T-CELL LARGE GRANULAR LYMPHOCYTE LEUKEMIA
Clinical trials for T-CELL LARGE GRANULAR LYMPHOCYTE LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new T-CELL LARGE GRANULAR LYMPHOCYTE LEUKEMIA trials appear
Sign up with your email to follow new studies for T-CELL LARGE GRANULAR LYMPHOCYTE LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill trial targets rare, Hard-to-Treat leukemia
Disease control Recruiting nowThis study is testing whether a pill called ruxolitinib can help control a rare type of blood cancer called T-cell large granular lymphocyte leukemia (T-LGLL). The drug aims to shrink tumors and improve low blood counts by blocking signals that help the cancer cells grow. Researc…
Matched conditions: T-CELL LARGE GRANULAR LYMPHOCYTE LEUKEMIA
Phase: PHASE2 • Sponsor: Jonathan Brammer • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New drug combo tested for Tough-to-Treat blood cancers
Disease control Recruiting nowThis early-stage study aims to find a safe and effective dose of two drugs, ruxolitinib and duvelisib, for adults whose T-cell or NK-cell lymphoma has returned or not responded to prior treatments. The main goal is to determine the highest dose patients can tolerate without sever…
Matched conditions: T-CELL LARGE GRANULAR LYMPHOCYTE LEUKEMIA
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 12, 2026 13:51 UTC